Cardea Healthcare- Bedford Ltd 15843659 false 2024-07-17 2025-07-31 2025-07-31 The principal activity of the company is Provision of care services Digita Accounts Production Advanced 6.30.9574.0 true 15843659 2024-07-17 2025-07-31 15843659 2025-07-31 15843659 core:RetainedEarningsAccumulatedLosses 2025-07-31 15843659 core:ShareCapital 2025-07-31 15843659 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 15843659 bus:SmallEntities 2024-07-17 2025-07-31 15843659 bus:AuditExemptWithAccountantsReport 2024-07-17 2025-07-31 15843659 bus:FilletedAccounts 2024-07-17 2025-07-31 15843659 bus:SmallCompaniesRegimeForAccounts 2024-07-17 2025-07-31 15843659 bus:RegisteredOffice 2024-07-17 2025-07-31 15843659 bus:Director1 2024-07-17 2025-07-31 15843659 bus:PrivateLimitedCompanyLtd 2024-07-17 2025-07-31 15843659 bus:Agent1 2024-07-17 2025-07-31 15843659 core:RetainedEarningsAccumulatedLosses 2024-07-17 2025-07-31 15843659 core:ShareCapital 2024-07-17 2025-07-31 15843659 countries:EnglandWales 2024-07-17 2025-07-31 iso4217:GBP xbrli:pure

Registration number: 15843659

Cardea Healthcare- Bedford Ltd
Unaudited Filleted Abridged Financial Statements
for the Period from 17 July 2024 to 31 July 2025

Cardea Healthcare- Bedford Ltd

Contents

Company Information | 1
Abridged Balance Sheet | 2
Statement of Changes in Equity | 3
Notes to the Unaudited Abridged Financial Statements | 4 to 5

Cardea Healthcare- Bedford Ltd

Company Information

Director | Zohib Yaqub

Registered office | Unit C11, Marquis Court Kingsway South Team Valley Trading Estate Gateshead Tyne & Wear NE11 0RU

Accountants | McManus Hall Chatered Accountants C11 Marquis Court Team Valley Gateshead Tyne and Wear NE11 0RU

Cardea Healthcare- Bedford Ltd

(Registration number: 15843659)
Abridged Balance Sheet as at 31 July 2025

| Note | 2025 £
Fixed assets |  |
Intangible assets | 4 | 24,000
Current assets |  |
Cash at bank and in hand |  | 7,759
Creditors: Amounts falling due within one year |  | (25,493)
Net current liabilities |  | (17,734)
Net assets |  | 6,266
Capital and reserves |  |
Called up share capital |  | 100
Retained earnings |  | 6,166
Shareholders' funds |  | 6,266

For the financial period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
• | The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 14 April 2026

.........................................

Zohib Yaqub

Director

Cardea Healthcare- Bedford Ltd

Statement of Changes in Equity for the Period from 17 July 2024 to 31 July 2025

| Share capital £ | Retained earnings £ | Total £
Profit for the period | - | 6,166 | 6,166
New share capital subscribed | 100 | - | 100
At 31 July 2025 | 100 | 6,166 | 6,266

Cardea Healthcare- Bedford Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 17 July 2024 to 31 July 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit C11, Marquis Court
Kingsway South
Team Valley Trading Estate
Gateshead
Tyne & Wear
NE11 0RU

These financial statements were authorised for issue by the director on 14 April 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cardea Healthcare- Bedford Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 17 July 2024 to 31 July 2025

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the period, was 4.

4 | Intangible assets

| Total £
Cost or valuation
Additions acquired separately | 24,000
At 31 July 2025 | 24,000
Amortisation
Carrying amount
At 31 July 2025 | 24,000